| Barbara Wood, CNS/PMH | |
|
4780 Ashford Dunwoody Rd Ste A-221, Atlanta, GA 30338-5564 | |
| (404) 228-9661 | |
| (866) 876-7892 |
| Full Name | Barbara Wood |
|---|---|
| Gender | Female |
| Speciality | Clinical Nurse Specialist - Psychiatric/mental Health, Geropsychiatric |
| Location | 4780 Ashford Dunwoody Rd Ste A-221, Atlanta, Georgia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235381187 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SP0813X | Clinical Nurse Specialist - Psychiatric/mental Health, Geropsychiatric | RN064757 (Georgia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Barbara Wood, CNS/PMH 4780 Ashford Dunwoody Rd Ste A-221, Atlanta, GA 30338-5564 Ph: (404) 228-9661 | Barbara Wood, CNS/PMH 4780 Ashford Dunwoody Rd Ste A-221, Atlanta, GA 30338-5564 Ph: (404) 228-9661 |
News Archive
Human articular cartilage defects can be treated with nasal septum cells. Researchers at the University and the University Hospital of Basel report that cells taken from the nasal septum are able to adapt to the environment of the knee joint and can thus repair articular cartilage defects.
The Virus in Diabetes International Study Group (VIDIS Group) has announced its formation and plans to launch an initiative to study in detail the relation between viruses and type I diabetes in childhood.
Advanced Medical Isotope Corporation, a late stage development company engaged primarily in the development of brachytherapy devices and medical isotopes for diagnostic and therapeutic applications, today announced that it has filed a de novo submission with the Food and Drug Administration for marketing clearance for its patented Y-90 RadioGel(TM) device pursuant to Section 513(f)(2) of the U.S. Food, Drug and Cosmetic Act.
Researchers at The Medicines Company presented data from a multi-national cohort that demonstrates the mortality and morbidity, and poor outcomes, associated with current therapies in patients with infections due to carbapenem-resistant Enterobacteriaceae (CRE). The data from this analysis has guided the design of the company's on-going clinical studies of its Phase 3 compound, CARBAVANCE® (meropenem/RPX7009) and was presented at the Interscience Conference of Antimicrobial Agents and Chemotherapy (ICAAC) and the International Congress of Chemotherapy and Infection (ICC) joint meeting in San Diego, CA.
› Verified 8 days ago
Micah Paulette Smith, NP Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 1364 Clifton Rd Ne, Atlanta, GA 30322 Phone: 404-712-7109 | |
Ms. Beverly Lynn Philson, PMHCNS-BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 80 Jesse Hill Jr Dr , Se, Atlanta, GA 30303 Phone: 404-616-4444 Fax: 404-616-4737 | |
Amanda Walter, MSN, APRN, AGCNS-BC Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 1000 Johnson Fy Rd Ne, Atlanta, GA 30342 Phone: 404-851-6123 | |
Erin Harlow-parker, RN,MS,CS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 101johnson Ferry Road, Atlanta, GA 30342 Phone: 404-785-5252 | |
Ann C Hixson, CNS Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 20 Glenlake Parkway, Department Of Behavioral Health, Atlanta, GA 30328 Phone: 770-677-7370 Fax: 770-677-7389 | |
Tina Taylor, CPNP Clinical Nurse Specialist Medicare: Medicare Enrolled Practice Location: 5461 Meridian Mark Rd Ste 400, Atlanta, GA 30342 Phone: 404-785-1112 Fax: 404-785-3600 |